240 related articles for article (PubMed ID: 14710231)
1. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.
Fondevila C; Metges JP; Fuster J; Grau JJ; Palacín A; Castells A; Volant A; Pera M
Br J Cancer; 2004 Jan; 90(1):206-15. PubMed ID: 14710231
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
3. VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer.
Wang X; Cao W; Mo M; Wang W; Wu H; Wang J
J Surg Oncol; 2010 Sep; 102(4):325-30. PubMed ID: 20589712
[TBL] [Abstract][Full Text] [Related]
4. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
5. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
6. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
7. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
Zha Y; Cun Y; Zhang Q; Li Y; Tan J
Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
11. [Expression of transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrating gastric cancer and their relationship with biological behavior and prognosis].
Wei YZ; Li CF; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):145-9. PubMed ID: 19296249
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
13. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
Yang LP; Fu LC; Guo H; Xie LX
Onkologie; 2012; 35(3):88-93. PubMed ID: 22414971
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
[TBL] [Abstract][Full Text] [Related]
19. Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.
Perrone G; Vincenzi B; Santini D; Verzì A; Tonini G; Vetrani A; Rabitti C
Cancer Lett; 2004 May; 208(2):227-34. PubMed ID: 15142682
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
